The purpose of this study is to determine whether genetic information associated with individual depressive symptoms.
The primary hypothesis is that the variations of the candidate genes are associated with individual symptoms in patients with depression. The Second hypothesis is that patients with the associated genetic variation suffer longer from the associated symptom than the patients without the associated genetic variation.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
1,000
Antidepressant administration of SSRI class for 12 weeks under therapeutic dose
Antidepressant administration of non-SSRI class for 12 weeks under therapeutic dose
Samsung Medical Center
Kangnam, Seoul, South Korea
RECRUITINGPresences of each individual symptom of depression at 1,2,4,6,12 weeks
17-items HAM-D scale was employed to measure depressive symptoms
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.